9 insiders reported 25 Form 4 transactions for Turn Therapeutics Inc. (TTRX) over the past 18 months (most recent 2026-06-01). Recent activity: Burnam Bradley Evan (Chief Executive Officer) Sell 300,000 shares, Burnam Bradley Evan (Chief Executive Officer) Buy 300,000 shares, BEB Holdings, LLC (10% Owner) Buy 300,000 shares, Burnam Bradley Evan (Chief Executive Officer) Buy 300,000 shares, BEB Holdings, LLC (10% Owner) Sell 300,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | Sell | 300,000 | $0 |
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | Buy | 300,000 | $0 |
| 2026-06-01 | BEB Holdings, LLC | 10% Owner | Buy | 300,000 | $0 |
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | Buy | 300,000 | $0 |
| 2026-06-01 | BEB Holdings, LLC | 10% Owner | Sell | 300,000 | $0 |
| 2026-06-01 | BEB Holdings, LLC | 10% Owner | Sell | 300,000 | $0 |
| 2026-06-01 | BEB Holdings, LLC | 10% Owner | Buy | 300,000 | $0 |
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | Sell | 300,000 | $0 |
| 2026-04-03 | GOLDEN ARTHUR F | Director | Buy | 300,000 | $0 |
| 2026-04-03 | BEB Holdings, LLC | 10% Owner | Sell | 300,000 | $0 |
| 2026-04-03 | Burnam Bradley Evan | Chief Executive Officer | Sell | 300,000 | $0 |
| 2026-02-04 | Dewhurst Martin William | Director | Buy | 21,882 | $0 |
| 2025-12-12 | Chaudhary Zuraiz | See Remarks | Buy | 2,500 | $8,750 |
| 2025-11-25 | GOLDEN ARTHUR F | Director | Buy | 9,868 | $33,946 |
| 2025-11-24 | GOLDEN ARTHUR F | Director | Buy | 20,532 | $58,927 |
| 2025-11-21 | Chaudhary Zuraiz | See Remarks | Buy | 1,450 | $3,784 |
| 2025-11-21 | Chaudhary Zuraiz | See Remarks | Buy | 1,000 | $3,290 |
| 2025-11-17 | Chaudhary Zuraiz | See Remarks | Buy | 2,500 | $9,050 |
| 2025-10-29 | Chesed Abraham | Insider | Buy | 14,286 | $65,716 |
| 2025-10-23 | Chaudhary Zuraiz | See Remarks | Buy | 5,050 | $24,998 |
| 2025-10-23 | GOLDEN ARTHUR F | Director | Buy | 20,202 | $100,000 |
| 2025-10-10 | GOLDEN ARTHUR F | Director | Buy | 10,000 | $0 |
| 2025-10-10 | Kester Kent Edward | Director | Buy | 10,000 | $0 |
| 2025-10-10 | Gengos Andrew | Director | Buy | 10,000 | $0 |
| 2025-10-10 | Ghodadra Neilesh Shailesh | Chief Medical Officer | Buy | 10,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-01